11e jaarlijks ECD Medical Symposium in Birmingham, AL

Gaurav Goyal, arts
Universiteit van Alabama in Birmingham
Birmingham, Alabama US
1 mei 2026

Birmingham Medical Symposium Group Picture 2026

Samenvatting van het symposium

Approximately 44 medical professionals from 6 countries attended the Annual ECD Medical Symposium in 2026. 15 oral abstracts were presented, along with an additional 9 poster presentations. The keynote speaker, Nicole Coufal, MD, PhD, delivered a talk titled “Diversity and Degeneration in Neurohistiocytic Disease.” An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.

Programma's met het symposiumprogramma

Agenda

PresentatorPresentatiedia’sEngelse video
Gaurav Goyal, artsDia bekijkenWelkom in Birmingham en op de 11e jaarlijkse internationale conferentie over de ziekte van Erdheim-Chester
Nicole Coufal, MD (Keynote Speaker)Dia bekijkenDiversiteit en degeneratie bij de neurohistiocytische aandoening
Benjamin Durham, artsDia bekijkenARAF-mutaties veroorzaken histiocytische neoplasmata in vivo en bieden inzicht in de cellulaire oorsprong
Florian Houdu, MDDia bekijkenTracking BRAF V600E Persistence under MEK Inhibition in Histiocytoses: a B-cell–enriched signal
Irena Ungureanu, MDDia bekijkenDistribution of MAP2K1 Variants Across Peripheral Blood Cells in Erdheim-Chester Disease and Other Histiocytoses
Matthew Collin, artsDia bekijkenThe Clonal Origin and Evolution of High-Risk Multisystem Histiocytosis in Adults
Dongni Yi, MDDia bekijkenKRAS-mutaties bij histiocytische neoplasmata: mutatiespectrum en respons op MEK-remming
Dongni Yi, MDDia bekijkenOverexpressie van cycline D1 veroorzaakt replicatiestress en leidt tot therapeutische kwetsbaarheden bij histiocytische neoplasmata
Jérôme Razanamahery, MDDia bekijkenClonal Hematopoiesis Predicts Response to Interferon-α in Erdheim-Chester Disease and Myeloproliferative Neoplasms
Félicien Triboulet, MDDia bekijkenImpact of Additional Genetic Variants in the Course of Erdheim-Chester Disease… a Multicentric Longitudinal Study of 445 French Patients
Guneet Janda, MDDia bekijkenPatterns of Presentation and Outcomes in Adults Xanthogranulomas
Mustafa Abomohsen, MDDia bekijkenNiet beschikbaar
Carla Isabel Borre, MDDia bekijkenReal World Frontline Systemic Anti-Cancer Treatment Patterns and Outcomes in Erdheim–Chester Disease
Gaurav Goyal, artsDia bekijkenBurden of Chronic Health Conditions After Diagnosis of Erdheim–Chester Disease (ECD): Early Results from the Histiocytic Disorder Survivor Study
Julien Haroche, arts, dr.Dia bekijkenDestombes-Rosai-Dorfman Disease: Clinical, Molecular Characteristics and Treatment Response: data from a retrospective cohort of 107 patients
Anneka Johnston, MDDia bekijkenConsiderations for Assessment and Treatment of Neuropsychiatric Symptoms in ECD
Matthew Collin, arts, dr.Dia bekijkenAll that glitters: retro-orbital xanthogranuloma or ECD?
Jithma Abeykoon, artsDia bekijkenDe aanwijzing was de bloeddruk: atypische ziekte van Erdheim–Chester
Jerome HensonECD Global Alliance: op weg naar de toekomstECD Global Alliance: op weg naar de toekomst

Foto's

Celebration Dinner

Medisch symposium

Medische receptie

Bijeenkomst zorgcentrum